Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. - Wikidata - awgldk - TriplyDB

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

http://www.wikidata.org/entity/Q36969911

about

Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.Single nucleotide polymorphisms in the 3'UTR of VPAC-1 cooperate in modulating gene expression and impact differently on the interaction with miR525-5p.Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells.Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis.Prediction of anti-inflammatory proteins/peptides: an insilico approach.Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response.Effect of VIP on the balance between cytokines and master regulators of activated helper T cells.

P2860

Q34238010-B2E6A4F7-7A8B-4810-AE31-51AB6DE03A45 Q34788079-10DC3A6E-7A15-4A2B-B9FB-B15B5AC8071C Q35414146-AE229CC4-3E6B-46B8-ADCD-7E6ACAEE6F6C Q35924965-7A730594-3F24-4AF2-B4BE-22E99E48A9F5 Q36432359-BE672C0A-2092-439A-B546-5E8B0024C689 Q37230862-DD5C3BFD-BBFA-4A22-A6B8-223605AF4915 Q37445090-591C9065-5ED8-4455-96E6-E56E0AFFF912 Q37563960-3E5C6482-3D30-46B4-A6A6-A29ADA41D42A Q39250380-364527A8-E4B3-4C90-9619-082E121A9EAA Q43554142-909B7806-449C-429C-8B75-E8CB8BBDE738

P2860

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

http://www.wikidata.org/entity/Q36969911

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

@en

type

label

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

@en

prefLabel

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

@en

P1433

Q36969911-8F7EDD36-433E-4FCC-A985-3BA8D7BAFB7F

P1476

Q36969911-41E2A467-0800-4B39-8DCD-055EEBE495DB

P2093

Q36969911-294CE064-782C-4A42-8B5B-3BC9BAE5D257

Q36969911-E08BE179-3C86-42D6-AC93-A4BC624B9BCF

Q36969911-E88D96A6-A26B-44B8-A79E-351F829EF6C2

P2860

Q36969911-03B882AA-4323-4681-9EB6-112E84E89632

Q36969911-07A90B1A-B47A-44E6-A7F5-698DF72F45AF

Q36969911-0E141250-A4CA-4F4F-9B51-82DE79ECED47

Q36969911-11986F3B-56F6-4488-B9FD-5CA8F72C5ACA

Q36969911-12562D77-F496-4AB2-AD74-F5E07088B5C3

Q36969911-1258A38A-CA02-4BCB-B726-F2A858B518CD

Q36969911-16E77CED-CE72-423A-8846-ECA7125F24BA

Q36969911-1AC13511-9D0B-4498-93C2-51BB26AAD120

Q36969911-1CA39981-4751-4B04-B4C1-057DA2DBF8C9

Q36969911-254394CD-0923-4C09-85A4-C3FC0DF3CC29

P304

Q36969911-71A5E1DE-E9CB-41CD-A114-F4042A18D7FB

P31

Q36969911-CFD0A70E-9D12-4C05-8EBD-8C82CB9E532F

P356

Q36969911-42CD71B2-0A7F-4D25-95DC-722F5CEBB221

P407

Q36969911-0513AFC3-FCA7-4AB0-96AB-2AD97EE2D292

P478

Q36969911-7561FD6F-5763-4AFE-9EDC-D152CFCA4C32

P577

Q36969911-8050BB10-A420-4A75-B20F-16776C511BC3

P5875

Q36969911-ACA2CB8C-5785-4BB2-85D1-8BD71A067427

P698

Q36969911-375BC217-173C-44D9-9E99-F83F08ADCB74

P932

Q36969911-487DC8A5-C00D-4D68-ABA2-EF4ABCACC624

P356

ARD.2007.078519

P1433

Annals of the Rheumatic Diseases

P1476

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

@en

P2093

Elena Gonzalez-Rey

http://www.w3.org/2001/XMLSchema#string

Mario Delgado

http://www.w3.org/2001/XMLSchema#string

Per Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

Evolving concepts of rheumatoid arthritis

VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.

Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

The significance of vasoactive intestinal peptide in immunomodulation.

Tolerogenic dendritic cells: cytokine modulation comes of age.

P304

iii70-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2007.078519

http://www.w3.org/2001/XMLSchema#string

P407

P478

66 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5911395

http://www.w3.org/2001/XMLSchema#string

P698

17934101

http://www.w3.org/2001/XMLSchema#string

P932

2095290

http://www.w3.org/2001/XMLSchema#string